Actionable news
0
All posts from Actionable news
Actionable news in KERX: Keryx Biopharmaceuticals, Inc.,

After A Lackluster Launch, Keryx's Auryxia Appears To Be Moving In The Right Direction According To Spherix Global Insights Gmbh

ZUG, Switzerland, Oct. 14, 2015 /PRNewswire/ -- Feedback gathered from300 US nephrologists in the last three releases of RealTime Dynamix: Bone and Mineral Metabolismsuggests that Auryxia is finally on the upswing. Despite strong buy-in to the benefits of Auryxia and a patient population that is largely above the target range for phosphorus, the brand has struggled to gain traction among nephrologists. However, between July and August that began to shift and results from September indicate an upward momentum.

In September, market share and the percent of nephrologists using Auryxia increased significantly, more first-line use was observed and persistency rates continued to be strong. Additionally, projected increases and intended trial by non-users also showed promise. Velphoro, another relatively new...


More